Compound Detail
CHEMBL5404877
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5404877 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | RMXCSUJEPVYRRE-QWRGUYRKSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
260.3
MW (Da)
2.18
ALogP
5
HBA
2
HBD
62.5
PSA (Ų)
0.89
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 7.1
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| CDK9/cyclin T1 CHEMBL2111389 | IC50 | 7.1 | 7.1 | 79.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| CDK9/cyclin T1 | IC50 | = | 79.0 | nM | 7.1 | Inhibition of human CDK9/Cyclin T1 preincubated for 20 mins followed by 32P-ATP ... | 37967851 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 37967851 | 10.1021/acs.jmedchem.3c01233 | CDK9/cyclin T1 | 1 |
Data from ChEMBL 36 via Core Engine